NEW YORK – Germany's government-funded health insurance will start covering three additional breast cancer biomarker tests that can help doctors and patients decide whether adjuvant chemotherapy after surgery is indicated.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.